Summary:
(This measure has not been amended since it was introduced. The summary of that version is repeated here.)

Transnational Drug Trafficking Act of 2013 - Amends the Controlled Substances Import and Export Act to prohibit the manufacture or distribution of a controlled substance in schedule I or II, flunitrazepam, or a listed chemical by individuals having reasonable cause to believe that such substance or chemical will be unlawfully imported into the United States or into waters within 12 miles of the U.S. coast.

Prohibits the manufacture or distribution of a listed chemical: (1) intending or knowing that it will be used to manufacture a controlled substance; and (2) intending, knowing, or having reasonable cause to believe that the substance will be unlawfully imported into the United States.

Amends the federal criminal code to revise the prohibition against, and penalties for, intentionally trafficking in a counterfeit drug to apply to intentionally trafficking in a drug and knowingly using a counterfeit mark on or in connection with such drug.

measure amended introduced summary version repeated transnational drug trafficking act amends controlled_substances_import_and_export_act prohibit manufacture distribution controlled substance schedule flunitrazepam listed chemical individuals having reasonable cause believe substance chemical unlawfully imported united_states waters miles coast prohibits manufacture distribution listed chemical intending knowing manufacture controlled substance intending knowing having reasonable cause believe substance unlawfully imported united_states amends federal criminal code revise prohibition penalties intentionally trafficking counterfeit drug apply intentionally trafficking drug knowingly counterfeit mark connection drug


Summary:
Servicemembers and Veterans Prescription Drug Safety Act of 2013 - Directs the Secretary of Defense (Secretary) and the Attorney General (AG) to jointly carry out a program under which a member of the Armed Forces (member), an individual receiving or entitled to military retired or retainer pay, a dependent-beneficiary of a member, or any person lawfully entitled to dispose of the property of any of such individuals may deliver a personal-use controlled substance (the prescription medication of a deceased individual) for disposal at a facility to be specified by the Secretary and the AG. Requires the Secretary and AG, in implementing the program, to develop appropriate guidelines and procedures to prevent the diversion, misuse, theft, or loss of such delivered substances.

Directs the Secretary and the AG to jointly carry out a program under which a veteran, a veteran's spouse or dependent, a person in receipt of medical services at a Department of Veterans Affairs (VA) facility, or any person lawfully entitled to dispose of the property of any of such individuals may deliver such a controlled substance for disposal at a specified facility, subject to the same guidelines and procedures with respect to such delivered substances.

servicemembers directs secretary defense secretary attorney general jointly carry program member armed_forces member individual receiving entitled military retired retainer pay dependent beneficiary member person lawfully entitled dispose property individuals deliver personal use controlled substance prescription medication deceased individual disposal facility specified secretary requires secretary implementing program develop appropriate guidelines procedures prevent diversion misuse theft loss delivered substances directs secretary jointly carry program veteran veteran spouse dependent person receipt medical services department_of_veterans_affairs facility person lawfully entitled dispose property individuals deliver controlled substance disposal specified facility subject guidelines procedures respect delivered substances


Summary:
Synthetic Abuse and Labeling of Toxic Substances Act of 2013 or the SALTS Act - Amends the Controlled Substances Act to provide that, in determining whether a controlled substance analogue was intended for human consumption, the following factors may be considered: (1) the marketing, advertising, and labeling of the substance; (2) the known efficacy or usefulness of the substance for the marketed, advertised, or labeled purpose; (3) the difference between the price at which the substance is sold and the price at which the substance it is purported to be or advertised as is normally sold; (4) the diversion of the substance from legitimate channels and the clandestine importation, manufacture, or distribution of the substance; and (5) whether the defendant knew or should have known that the substance was intended to be consumed by injection, inhalation, ingestion, or any other immediate means.

Declares that evidence that a substance was not marketed, advertised, or labeled for human consumption shall not by itself be sufficient to establish that the substance was not intended for human consumption.

labeling toxic substances act salts act amends controlled substances act provide determining controlled substance analogue intended human consumption following factors considered marketing advertising labeling substance known efficacy usefulness substance marketed advertised labeled purpose difference price substance sold price substance purported advertised normally sold diversion substance legitimate channels clandestine importation manufacture distribution substance defendant knew known substance intended consumed injection inhalation ingestion immediate means declares evidence substance marketed advertised labeled human consumption shall sufficient establish substance intended human consumption


Summary:
Protecting Our Youth from Dangerous Synthetic Drugs Act of 2013 - Amends the Controlled Substances Act to include in the definition of a "controlled substance analogue" a substance designated as such by the Controlled Substance Analogue Committee (established by this Act).

Directs the Attorney General to establish such Committee as an interagency committee headed by the Administrator of the Drug Enforcement Administration (DEA) and comprised of scientific experts in the fields of chemistry and pharmacology from DEA, the National Institute on Drug Abuse, the Centers for Disease Control and Prevention (CDC), and any other federal agency determined by the Attorney General to be appropriate.

 Requires the Committee to designate, and establish and maintain a list of, controlled substance analogues determined to be similar to a schedule I or II controlled substance in either chemical structure or predictive effect on the body in such a manner as to make it likely that the substance will, or can be reasonably expected to, have a potential for abuse. Directs the Administrator to publish a description of each designation made by the Committee.

Amends the Controlled Substances Import and Export Act to prohibit the importation of any controlled substance analogue except pursuant to such notification or declaration as the Attorney General may prescribe.

Directs the U.S. Sentencing Commission to review and, if appropriate, amend the federal sentencing guidelines and policy statements to ensure that they provide adequate penalties for any offense involving the unlawful manufacturing, importing, exporting, or trafficking of controlled substance analogues and similar offenses.

protecting youth dangerous synthetic drugs act amends controlled substances act include definition controlled substance analogue substance designated established act directs attorney general establish committee interagency committee headed administrator drug_enforcement_administration dea comprised scientific experts fields chemistry pharmacology dea centers_for_disease_control_and_prevention cdc federal agency determined attorney general appropriate requires committee designate establish maintain list controlled substance determined similar schedule controlled substance chemical structure predictive effect body manner likely substance reasonably expected potential abuse directs administrator publish description designation committee amends controlled_substances_import_and_export_act prohibit importation controlled substance analogue pursuant notification declaration attorney general prescribe directs review appropriate amend federal sentencing guidelines policy statements ensure provide adequate penalties offense involving unlawful manufacturing importing exporting trafficking controlled substance similar offenses


Summary:
Saving Kids from Dangerous Drugs Act of 2013 - Amends the Controlled Substances Act to make it unlawful for any person at least 18 years of age to: (1) knowingly or intentionally manufacture or create a Schedule I or II controlled substance that is combined with a beverage or candy product, marketed or packaged to appear similar to a beverage or candy product, or modified by flavoring or coloring; and (2) know, or have reasonable cause to believe, that the combined, marketed, packaged, or modified controlled substance will be distributed, dispensed, or sold to a person under 18 years of age.

Imposes enhanced criminal penalties for violations (not more than 10 years for a first offense or 20 years for a subsequent offense, involving the same controlled substance and schedule).

 Exempts any controlled substance that has been approved by the Secretary of Health and Human Services (HHS) under the drug approval process or that has been altered at the direction of a medical practitioner for a legitimate medical purpose.

Directs the United States Sentencing Commission to review its guidelines and policy statements to reflect the enhanced penalties provided by this Act.

saving kids dangerous drugs act amends controlled substances act unlawful person years age knowingly intentionally manufacture create schedule controlled substance combined beverage candy product marketed packaged appear similar beverage candy product modified flavoring coloring know reasonable cause believe combined marketed packaged modified controlled substance distributed dispensed sold person years age imposes enhanced criminal penalties violations years offense years subsequent offense involving controlled substance schedule exempts controlled substance approved secretary health_and_human_services hhs drug approval process altered direction medical practitioner legitimate medical purpose directs united_states_sentencing_commission review guidelines policy statements reflect enhanced penalties provided act


Summary: Protecting Lands Against Narcotics Trafficking Act of 2013 or the PLANT Act - Amends the Controlled Substances Act to: (1) impose an additional term of up to ten years' imprisonment for cultivating or manufacturing controlled substances on federal property; (2) prohibit a person, while cultivating or manufacturing a controlled substance on federal property, from clear cutting timber or diverting, obstructing, or draining an aquifer, spring, stream, river or body of water; and (3) apply the prohibition against assembling, maintaining, or placing a booby trap on federal property where a controlled substance is being manufactured to federal property where a controlled substance is being cultivated. Directs the U.S. Sentencing Commission to amend and review the Federal Sentencing Guidelines to provide for a penalty enhancement of not less than one offense level for manufacturing, distributing, or dispensing, or possessing with intent to manufacture, distribute, or dispense a controlled substance or a counterfeit substance while on federal property or intentionally trespassing on the property of another if such offense: (1) includes the use of a poison, chemical, or other hazardous substance to cultivate or manufacture controlled substances; (2) creates a hazard to humans, wildlife, or domestic animals; (3) degrades or harms the environment or natural resources; (4) pollutes an aquifer, spring, stream, river, or body of water; (5) involves the diversion, redirection, obstruction, or draining of an aquifer, spring, stream, river, or body of water or the clear cut of timber while cultivating or manufacturing a controlled substance; or (6) involves the possession of a firearm while cultivating or manufacturing controlled substances.

trafficking act plant act amends controlled substances act impose additional term years imprisonment cultivating manufacturing controlled substances federal property prohibit person cultivating manufacturing controlled substance federal property clear cutting timber diverting obstructing draining aquifer spring stream river body water apply prohibition assembling maintaining placing trap federal property controlled substance manufactured federal property controlled substance cultivated directs amend review federal sentencing guidelines provide penalty enhancement offense level manufacturing distributing dispensing possessing intent manufacture distribute dispense controlled substance counterfeit substance federal property intentionally trespassing property offense includes use poison chemical hazardous substance manufacture controlled substances creates hazard humans wildlife domestic animals harms environment natural resources aquifer spring stream river body water involves diversion obstruction draining aquifer spring stream river body water clear cut timber cultivating manufacturing controlled substance involves possession firearm cultivating manufacturing controlled substances


Summary:
Designer Anabolic Steroid Control Act of 2014 - Amends the Controlled Substances Act to:  (1) expand the list of substances defined as "anabolic steroids"; (2) authorize the Attorney General to issue a temporary order adding a drug or other substance to the list of anabolic steroids; (3) impose enhanced criminal and civil penalties for possessing or trafficking in any anabolic steroid, or product containing an anabolic steroid, unless it bears a label clearly identifying the anabolic steroid by the nomenclature used by the International Union of Pure and Applied Chemistry; and (4) authorize the Attorney General to collect data and analyze products to determine whether they contain anabolic steroids and are properly labeled.

Specifies that a substance shall not be considered to be a drug or hormonal substance that is considered to be an anaboloic steroid if it is: (1) an herb or other botanical; (2) a concentrate, metabolite, or extract of, or a constituent isolated directly from, an herb or other botanical; (3) a combination of two or more such substances (i.e., botanical or concentrate, metabolite, or extract); or (4) a dietary ingredient for purposes of the Federal Food, Drug, and Cosmetic Act. Provides that any person claiming the benefit of an exemption or exception from being considered a drug or hormonal substance shall bear the burden of providing the appropriate evidence.

Directs: (1) the United States Sentencing Commission to review and amend federal sentencing guidelines with respect to offenses involving anabolic steroids, and (2) the Administrator of the Drug Enforcement Administration (DEA) to report every two years on what anabolic steroids have been scheduled on a temporary basis under this Act.

designer anabolic steroid control act amends controlled substances act expand list substances defined anabolic steroids authorize attorney general issue temporary order adding drug substance list anabolic steroids impose enhanced criminal civil penalties possessing trafficking anabolic steroid product containing anabolic steroid bears label clearly identifying anabolic steroid international_union_of_pure_and_applied_chemistry authorize attorney general collect data analyze products determine contain anabolic steroids properly labeled specifies substance shall considered drug substance considered steroid botanical concentrate extract constituent isolated directly botanical combination substances botanical concentrate extract dietary ingredient purposes cosmetic act provides person claiming benefit exemption exception considered drug substance shall bear burden providing appropriate evidence directs united_states_sentencing_commission review amend federal sentencing guidelines respect offenses involving anabolic steroids administrator drug_enforcement_administration dea report years anabolic steroids scheduled temporary basis act


Summary: Drug-Free Playgrounds Safety Enhancement Act of 2014 - Amends provisions of the Controlled Substances Act prescribing enhanced penalties for distributing or manufacturing drugs in or near certain facilities, such as schools, playgrounds, youth centers, and swimming pools, to: (1) include among such facilities a video amusement game facility (currently, a video arcade facility); (2) define a "video amusement game facility" as any facility that is legally accessible to persons under 18 years of age, that is intended primarily for amusement, and that contains video game machines or other similar youth games; and (3) revise the definition of "playground" to mean any outdoor area that is intended for recreation, that is open to the public, and that contains one or more apparatus intended for the recreation of children, including play structures, sliding boards, swingsets, seesaws, merry-go-rounds, slides, jungle gyms, chin-up bars, sandboxes, spring riders, monkey bars, overhead ladders, trapeze rings, playhouses, rope bridges, and mazes.

drug free safety enhancement act amends provisions controlled substances act prescribing enhanced penalties distributing manufacturing drugs near certain facilities schools youth centers swimming pools include facilities video amusement game facility currently video facility define video amusement game facility facility legally accessible persons years age intended primarily amusement contains video game machines similar youth games revise definition mean outdoor area intended recreation open public contains apparatus intended recreation children including play structures sliding boards rounds bars spring riders bars overhead rings bridges


Summary:
Heroin and Prescription Opioid Abuse Prevention, Education, and Enforcement Act of 2014 - Directs the Secretary of Health and Human Services (HHS) to convene a Pain Management Best Practices Inter-Agency Task Force.

 Reauthorizes the Harold Rogers Prescription Drug Monitoring Program through FY2019. Requires the Comptroller General (GAO) to report on the effectiveness of the program in reducing prescription drug abuse and any corresponding increase or decrease in the use of heroin.

Amends the Omnibus Crime Control and Safe Streets Act of 1968 to reauthorize the Edward Byrne Memorial Justice Assistance Grant Program through FY2019.

Requires the Director of the Office of National Drug Control Policy (ONDCP) to:

 revise the 2011 Prescription Drug Abuse Prevention Plan to reassess the approach to addressing prescription drug abuse in light of an increase in heroin use and to outline actions or programs to reduce and prevent such abuse, and ensure that ONDCP takes into account a specified GAO report concerning program coordination and identifies opportunities to enhance interagency coordination as part of the Plan. Requires the Secretary to advance the education and awareness of providers, patients, and stakeholders regarding the risk of abuse of prescription opioid drugs if such products are not taken as prescribed. Directs ONDCP to establish a national drug awareness campaign that: takes into account the association between prescription opioid abuse and heroin use, and emphasizes the similarities between heroin and prescription opioids and the effects of these on the human body.

heroin prescription opioid abuse prevention education enforcement act directs secretary health_and_human_services hhs convene pain management best practices inter agency task force reauthorizes harold rogers prescription drug monitoring program fy2019 requires comptroller general gao report effectiveness program reducing prescription drug abuse corresponding increase decrease use heroin amends omnibus_crime_control_and_safe_streets_act reauthorize edward_byrne_memorial_justice assistance grant program fy2019 requires director office_of_national_drug_control_policy revise prescription drug abuse prevention plan reassess approach addressing prescription drug abuse light increase heroin use outline actions programs reduce prevent abuse ensure takes account specified gao report concerning program coordination identifies opportunities enhance interagency coordination plan requires secretary advance education awareness providers patients stakeholders risk abuse prescription opioid drugs products taken prescribed directs establish national drug awareness campaign takes account association prescription opioid abuse heroin use emphasizes similarities heroin prescription opioids effects human body


Summary:
Fifth Amendment Integrity Restoration Act of 2014 or the FAIR Act - Amends the federal criminal code to increase the federal government's burden of proof in civil forfeiture proceedings to clear and convincing evidence. Requires the government, in addition to showing a substantial connection between the seized property and the offense in a forfeiture proceeding, to establish by clear and convincing evidence that the owner of any interest in the seized property intentionally used the property in connection with the offense or knowingly consented or was willfully blind to the use of the property by another in connection with the offense.

Requires proceeds from the disposition of forfeited property to be deposited into the General Fund of the Treasury, rather than to Department of Justice (DOJ) accounts for law enforcement activities.

fair act amends federal criminal code increase federal government burden proof civil forfeiture proceedings clear convincing evidence requires government addition showing substantial connection seized property offense forfeiture proceeding establish clear convincing evidence owner interest seized property intentionally property connection offense knowingly consented willfully blind use property connection offense requires proceeds disposition forfeited property deposited general_fund treasury department_of_justice doj accounts law enforcement activities


Summary:
Reclassification to Ensure Smarter and Equal Treatment Act of 2014 or the RESET Act - Amends the Controlled Substances Act (CSA) to reduce penalties (to not greater than a one-year term of imprisonment and/or a $1,000 fine) for simple possession of a controlled substance by a person who has one or more prior convictions for a controlled substance offense. Repeals a provision providing for up to three years' imprisonment for the possession of flunitrazepam. Reduces the maximum term of imprisonment (to one year) for the sale, use of the mails to transport, or importation or exportation of drug paraphernalia.

Eliminates provisions of the CSA and the Controlled Substances Import and Export Act that apply the same penalties applicable to offenses involving a specified amount of a substance containing cocaine to offenses involving a lesser amount of a substance containing cocaine base.

Amends the CSA to provide that in determining the weight of a controlled substance or mixture of controlled substances that is in a compound with a food product for purposes of provisions concerning controlled substance offenses, the weight of the food product shall not be included.

reclassification ensure smarter equal treatment act reset act amends controlled substances act csa reduce penalties greater year term imprisonment fine simple possession controlled substance person prior convictions controlled substance offense repeals provision providing years imprisonment possession flunitrazepam reduces maximum term imprisonment year sale use mails transport importation exportation drug eliminates provisions csa controlled_substances_import_and_export_act apply penalties applicable offenses involving specified substance containing cocaine offenses involving lesser substance containing cocaine base amends csa provide determining weight controlled substance mixture controlled substances compound food product purposes provisions concerning controlled substance offenses weight food product shall included


Summary: Ensuring Safe Access to Prescription Medication Act of 2014 - Amends the Controlled Substances Act to modify the definition of "dispense" to include the delivery of a controlled substance by a pharmacy to a practitioner, if: (1) such delivery is pursuant to a patient-specific prescription of the practitioner; and (2) the practitioner has deemed that it is medically necessary, acting in the usual course of professional practice, for the controlled substance to be administered by the practitioner to the patient.

ensuring safe access prescription medication act amends controlled substances act modify definition dispense include delivery controlled substance pharmacy practitioner delivery pursuant patient specific prescription practitioner practitioner deemed medically necessary acting usual course professional practice controlled substance administered practitioner patient


Summary:
Comprehensive Addiction and Recovery Act of 2014 - Directs the Secretary of Health and Human Services (HHS) to convene a Pain Management Best Practices Inter-Agency Task Force to develop: (1) best practices for pain management and prescribing pain medication, and (2) a strategy for disseminating such best practices.

Authorizes the Attorney General to make grants to:

 states, local governments, and nonprofit organizations to expand educational efforts to prevent abuse of opioids, heroin, and other substances of abuse, understand addiction as a chronic disease, and promote treatment and recovery; organizations that have received a grant under the Drug-Free Communities Act of 1997 to implement comprehensive community-wide strategies that address local drug crises; states, local governments, Indian tribes, and nonprofit organizations for treatment alternative to incarceration programs for individuals who have come into contact with the criminal justice system, have a substance use disorder, mental illness, or both, and have been approved for participation in such a program; state, local, or tribal law enforcement agencies to create a pilot law enforcement program to prevent opioid and heroin overdose death and to expand or make available disposal sites for unwanted prescription medications; states, local governments, and Indian tribes to implement medication assisted treatment programs through their criminal justice agencies; states, local governments, nonprofit organizations, and Indian tribes for educational programs for incarcerated offenders; state substance abuse and criminal justice agencies, jointly, to address the use of opioids and heroin among pregnant and parenting female offenders in a state to promote public safety, public health, family permanence, and well-being; establish or expand veterans treatment court programs, peer to peer services or programs for qualified veterans, practices that identify and provide treatment, rehabilitation, legal, and transitional services to incarcerated veterans, and training programs to teach criminal justice, mental health, and substance abuse personnel how to identify and appropriately respond to incidents involving veterans; and states to prepare a comprehensive plan for and implement an integrated opioid abuse response initiative. Amends the Public Health Service Act to authorize the Director of the Center for Substance Abuse Treatment to award grants to enable state substance abuse agencies, local governments, nonprofit organizations, and Indian tribes or tribal organizations that have a high rate of, or have had a rapid increase in, the use of heroin or other opioids to expand activities, including medication assisted treatment, for the treatment of addiction in the geographical areas affected.

Authorizes the Recovery Branch of the Office of National Drug Control Policy to award grants to: (1) enable high schools and colleges with substance abuse recovery programs and nonprofit organizations to provide substance abuse recovery support services to high school and college students, to help build communities of support for young people in recovery, and to encourage initiatives designed to help young people achieve and sustain recovery; and (2) enable recovery community organizations to develop, expand, and enhance recovery services.

Amends the Higher Education Act of 1965 to prohibit the Secretary of Education from including any question about the conviction of an applicant for the possession or sale of illegal drugs on the Free Application for Federal Student Aid form.

Directs the HHS Secretary to establish a bipartisan Task Force on Recovery and Collateral Consequences to: (1) identify collateral consequences for individuals with drug convictions who are in recovery for a substance use disorder, and (2) determine whether such consequences unnecessarily delay such individuals from resuming their personal and professional activities.

Amends the Omnibus Crime Control and Safe Streets Act to direct the Attorney General to report annually on how grants awarded under such Act are used for family-based substance abuse treatment programs that serve as alternatives to incarceration for custodial parents to receive treatment and services as a family.

comprehensive addiction recovery act directs secretary health_and_human_services hhs convene pain management best practices inter agency task force develop best practices pain management prescribing pain medication strategy disseminating best practices authorizes attorney general grants states local governments nonprofit organizations expand educational efforts prevent abuse opioids heroin substances abuse understand addiction chronic disease promote treatment recovery organizations received grant implement comprehensive community wide strategies address local drug crises states local governments indian tribes nonprofit organizations treatment alternative incarceration programs individuals come contact criminal justice system substance use disorder mental illness approved participation program state local tribal law enforcement agencies create pilot law enforcement program prevent opioid heroin overdose death expand available disposal sites unwanted prescription medications states local governments indian tribes implement medication assisted treatment programs criminal justice agencies states local governments nonprofit organizations indian tribes educational programs incarcerated offenders state substance abuse criminal justice agencies jointly address use opioids heroin pregnant parenting female offenders state promote public safety public health family establish expand veterans treatment court programs peer peer services programs qualified veterans practices identify provide treatment rehabilitation legal transitional services incarcerated veterans training programs teach criminal justice mental health substance abuse personnel identify appropriately respond incidents involving veterans states prepare comprehensive plan implement integrated opioid abuse response initiative amends public_health_service_act authorize director center_for_substance_abuse_treatment award grants enable state substance abuse agencies local governments nonprofit organizations indian tribes tribal organizations high rate rapid increase use heroin opioids expand activities including medication assisted treatment treatment addiction geographical areas affected authorizes recovery branch office_of_national_drug_control_policy award grants enable high schools colleges substance abuse recovery programs nonprofit organizations provide substance abuse recovery support services high school college students help build communities support young people recovery encourage initiatives designed help young people achieve sustain recovery enable recovery community organizations develop expand enhance recovery services amends higher education act prohibit secretary education including question conviction applicant possession sale illegal drugs free_application_for_federal_student_aid form directs hhs secretary establish bipartisan task force recovery collateral consequences identify collateral consequences individuals drug convictions recovery substance use disorder determine consequences unnecessarily delay individuals resuming personal professional activities amends omnibus_crime_control_and_safe_streets_act direct attorney general report annually grants awarded act family based substance abuse treatment programs serve alternatives incarceration custodial parents receive treatment services family


Summary:
Regulatory Transparency, Patient Access, and Effective Drug Enforcement Act of 2014 - Amends the Controlled Substances Act to direct the Attorney General, within 45 days of receiving a recommendation from the Secretary of Health and Human Services (HHS) to add a drug or substance that has never been marketed in the United States to a schedule of controlled substances, to issue an interim final rule under the exception for good cause, placing it into the schedule recommended, effective immediately.

Allows a person who submits an application for registration to manufacture or distribute a controlled substance to indicate on the registration application that the substance will be used only in connection with clinical trials of a drug. Requires the Attorney General to: (1) make a final decision on such application within 180 days, or (2) provide written notice to the applicant of the outstanding issues that must be resolved to reach a final decision and the estimated date on which such decision will be made.

Defines: (1) "factors as may be relevant to and consistent with the public health and safety," and (2) "imminent danger to the public health or safety."

Requires an order to show cause as to why a registration should not be denied, revoked, or suspended to notify the registrant of the opportunity to submit a corrective action plan on or before the date of appearance before the Attorney General. Requires the Attorney General, upon review of any such plan, to determine whether denial, revocation, or suspension proceedings should be discontinued or deferred for purposes of modification or clarification of such plan. Makes these requirements inapplicable to the issuance of an immediate suspension order.

Directs the Secretary, acting through the Commissioner of Food and Drugs (FDA) and the Director of the Centers for Disease Control and Prevention (CDC), to identify: (1) obstacles to legitimate patient access to controlled substances; (2) issues with diversion of controlled substances; and (3) how collaboration between federal, state, local, and tribal law enforcement agencies and the pharmaceutical industry can benefit patients and prevent diversion and abuse of controlled substances.

regulatory transparency effective drug enforcement act amends controlled substances act direct attorney general days receiving recommendation secretary health_and_human_services hhs add drug substance marketed united_states schedule controlled substances issue interim final rule exception good cause placing schedule recommended effective immediately allows person submits application registration manufacture distribute controlled substance indicate registration application substance connection clinical trials drug requires attorney general final decision application days provide written notice applicant outstanding issues resolved reach final decision estimated date decision defines factors relevant consistent public health safety imminent danger public health safety requires order cause registration denied revoked suspended notify registrant opportunity submit corrective action plan date appearance attorney general requires attorney general review plan determine denial revocation suspension proceedings discontinued deferred purposes modification clarification plan makes requirements inapplicable issuance immediate suspension order directs secretary acting commissioner food drugs fda director centers_for_disease_control_and_prevention cdc identify obstacles legitimate patient access controlled substances issues diversion controlled substances collaboration federal state local tribal law enforcement agencies pharmaceutical industry benefit patients prevent diversion abuse controlled substances


Summary:
No More Tulias: Drug Law Enforcement Evidentiary Standards Improvement Act of 2015

This bill prohibits a state from receiving for a fiscal year any drug control and system improvement (Byrne) grant funds under the Omnibus Crime Control and Safe Streets Act of 1968, or any amount from any other federal law enforcement assistance program, unless the state does not fund any antidrug task forces for that fiscal year or it has in effect laws that ensure that: (1) a person is not convicted of a drug offense unless the fact that a drug offense was committed and the person's commission of the offense are supported by evidence other than the eyewitness testimony of a law enforcement officer or those acting on an officer's behalf, and (2) an officer may participate in an antidrug task force only if that officer's honesty and integrity are evaluated and found to be at an appropriately high level.

 States receiving federal funds under this bill are directed to collect data on the racial distribution of drug charges, the nature of the criminal law specified in the charges, and the jurisdictions in which such charges are made.

drug law enforcement evidentiary standards improvement act bill prohibits state receiving fiscal year drug control system improvement byrne grant funds omnibus_crime_control_and_safe_streets_act federal law enforcement assistance program state fund antidrug task forces fiscal year effect laws ensure person convicted drug offense fact drug offense committed person commission offense supported evidence eyewitness testimony law enforcement officer acting officer behalf officer participate antidrug task force officer honesty integrity evaluated found appropriately high level states receiving federal funds bill directed collect data racial distribution drug charges nature criminal law specified charges jurisdictions charges


Summary:
States' Medical Marijuana Property Rights Protection Act

 Exempts real property from civil forfeiture under the Controlled Substances Act due to medical marijuana-related conduct that is authorized by state law.

states medical marijuana property rights protection act exempts real property civil forfeiture controlled substances act medical marijuana related conduct authorized state law


Summary:
Ensuring Patient Access and Effective Drug Enforcement Act of 2015

 (Sec. 2) Amends the Controlled Substances Act to define: (1) "factors as may be relevant to and consistent with the public health and safety," for purposes of the Attorney General's determination of whether registering an applicant to manufacture or distribute a controlled substance in schedule I or II is in the public interest, as factors that are relevant to and consistent with the findings of such Act; and (2) "imminent danger to the public health or safety," for purposes of the suspension of such a registration, to mean that in the absence of an immediate suspension order, controlled substances will continue to be distributed or dispensed by a registrant who knows or should know through fulfilling the obligations of the registrant under this Act that the dispensing is outside the usual course of professional practice, the distribution or dispensing poses a present or foreseeable risk of adverse health consequences or death due to the abuse or misuse of the controlled substances, or the controlled substances will continue to be diverted outside of legitimate distribution channels.

Requires an order to show cause as to why such a registration should not be denied, revoked, or suspended to: (1) contain a statement of the basis for the denial, revocation, or suspension, including specific citations to any laws or regulations alleged to be violated; (2) direct the applicant or registrant to appear before the Attorney General at a specific place and time within 30 days after receipt of the order; and (3) notify the applicant or registrant of the opportunity to submit a corrective action plan on or before such appearance. Requires the Attorney General, upon review of any such plan, to determine whether denial, revocation, or suspension proceedings should be discontinued or deferred for purposes of modifications to such plan. Makes such requirements inapplicable to the issuance of an immediate suspension order.

(Sec. 3) Directs the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs and the Director of the Centers for Disease Control and Prevention, to submit a report identifying: (1) obstacles to legitimate patient access to controlled substances; (2) issues with diversion of controlled substances; and (3) how collaboration between federal, state, local, and tribal law enforcement agencies and the pharmaceutical industry can benefit patients and prevent diversion and abuse of controlled substances.

ensuring patient access effective drug enforcement act sec amends controlled substances act define factors relevant consistent public health safety purposes attorney general determination registering applicant manufacture distribute controlled substance schedule public interest factors relevant consistent findings act imminent danger public health safety purposes suspension registration mean absence immediate suspension order controlled substances continue distributed dispensed registrant knows know fulfilling obligations registrant act dispensing outside usual course professional practice distribution dispensing poses present foreseeable risk adverse health consequences death abuse misuse controlled substances controlled substances continue diverted outside legitimate distribution channels requires order cause registration denied revoked suspended contain statement basis denial revocation suspension including specific citations laws regulations alleged violated direct applicant registrant appear attorney general specific place time days receipt order notify applicant registrant opportunity submit corrective action plan appearance requires attorney general review plan determine denial revocation suspension proceedings discontinued deferred purposes modifications plan makes requirements inapplicable issuance immediate suspension order sec directs secretary health_and_human_services acting commissioner food_and_drugs director centers_for_disease_control_and_prevention submit report identifying obstacles legitimate patient access controlled substances issues diversion controlled substances collaboration federal state local tribal law enforcement agencies pharmaceutical industry benefit patients prevent diversion abuse controlled substances


Summary:
Industrial Hemp Farming Act of 2015

 Amends the Controlled Substances Act to exclude industrial hemp from the definition of "marihuana." Defines "industrial hemp" to mean the plant Cannabis sativa L. and any part of such plant, whether growing or not, with a delta-nine tetrahydrocannabinol concentration of not more than 0.3 percent on a dry weight basis. Deems Cannabis sativa L. to meet that concentration limit if a person grows or processes it for purposes of making industrial hemp in accordance with state law.

industrial hemp farming act amends controlled substances act exclude industrial hemp definition marihuana defines industrial hemp mean plant cannabis sativa plant growing delta tetrahydrocannabinol concentration percent dry weight basis sativa meet concentration limit person grows processes purposes making industrial hemp accordance state law


Summary:
Fifth Amendment Integrity Restoration Act of 2015 or the FAIR Act

This bill modifies general rules governing civil forfeiture proceedings to: (1) ensure that a person contesting a civil forfeiture has legal representation without regard to whether the property subject to forfeiture is being used by such person as a primary residence; (2) increase the federal government's burden of proof in civil forfeiture proceedings to clear and convincing evidence; (3) require the government, in addition to showing a substantial connection between the seized property and an offense, to establish by clear and convincing evidence that the owner of any interest in the seized property used the property with intent to facilitate the offense or knowingly consented or was willfully blind to the use of the property by another in connection with the offense; and (4) expand the proportionality criteria used by a court to determine whether a civil forfeiture was constitutionally excessive.

To remove incentives for carrying out civil forfeitures, the bill requires proceeds from the disposition of seized property to be deposited into the General Fund of the Treasury, rather than to Department of Justice accounts for law enforcement activities.

The bill adds a scienter requirement (i.e., a knowing violation) to the prohibition against structuring financial transactions to evade reporting requirements.

The bill requires: (1) a court to conduct a probable cause hearing to determine if there is a violation of the prohibition against structuring transactions to evade reporting requirements involving a monetary instrument and to return such instrument if probable cause is not established, and (2) the Attorney General to specify in reports to Congress and the public on forfeitures the amounts received from criminal and civil forfeitures.

fair act bill modifies general rules governing civil forfeiture proceedings ensure person contesting civil forfeiture legal representation regard property subject forfeiture person primary residence increase federal government burden proof civil forfeiture proceedings clear convincing evidence require government addition showing substantial connection seized property offense establish clear convincing evidence owner interest seized property property intent facilitate offense knowingly consented willfully blind use property connection offense expand criteria court determine civil forfeiture constitutionally excessive remove incentives carrying civil forfeitures bill requires proceeds disposition seized property deposited general_fund treasury department_of_justice accounts law enforcement activities bill adds requirement knowing violation prohibition structuring financial transactions evade reporting requirements bill requires court conduct probable cause hearing determine violation prohibition structuring transactions evade reporting requirements involving monetary instrument return instrument probable cause established attorney general specify reports congress public forfeitures amounts received criminal civil forfeitures


Summary:
Smarter Sentencing Act of 2015

 Amends the federal criminal code to direct the court to impose a sentence for specified controlled substance offenses without regard to any statutory minimum sentence if the court finds that the criminal history category for the defendant is not higher than category two. (Currently, the court may disregard the statutory minimum if the defendant does not have more than one criminal history point.)

Authorizes a court that imposed a sentence for a crack cocaine possession or trafficking offense committed before August 3, 2010, on motion of the defendant, the Bureau of Prisons, the attorney for the government, or the court, to impose a reduced sentence as if provisions of the Fair Sentencing Act of 2010 were in effect at the time such offense was committed, provided such sentence was not previously imposed or reduced under such Act or such a motion wasn't previously denied.

Amends the Controlled Substances Act (CSA) and the Controlled Substances Import and Export Act (CSIEA) to reduce mandatory minimum sentences for manufacturing, distributing, dispensing, possessing, importing, or exporting specified controlled substances and for such violations by a courier (defined as a person whose role was limited to transporting or storing drugs or money).

Directs the U.S. Sentencing Commission to review and amend its guidelines and policy statements applicable to persons convicted of such an offense under the CSA and CSIEA to ensure consistency with this Act and to consider specified factors, including: (1) its mandate to formulate guidelines to minimize the likelihood that the federal prison population will exceed federal prison capacity, and (2) the need to reduce and prevent racial disparities in sentencing.

Requires the Attorney General to: (1) report on how the reduced expenditures on federal corrections and cost savings resulting from this Act will be used to help reduce overcrowding in the Bureau of Prisons, increase investment in law enforcement and crime prevention, and reduce recidivism; (2) report a list of all criminal statutory offenses and the potential criminal penalty, the number of prosecutions brought by the Department of Justice each year for the previous 15 years, and the mens rea requirement for each offense; and (3) establish a publicly accessible index of each criminal statutory offense.

amends federal criminal code direct court impose sentence specified controlled substance offenses regard statutory minimum sentence court finds criminal history category defendant higher category currently court disregard statutory minimum defendant criminal history point authorizes court imposed sentence crack cocaine possession trafficking offense committed august motion defendant bureau_of_prisons attorney government court impose reduced sentence provisions fair sentencing act effect time offense committed provided sentence previously imposed reduced act motion previously denied amends controlled substances act csa controlled_substances_import_and_export_act csiea reduce mandatory minimum sentences manufacturing distributing dispensing possessing importing exporting specified controlled substances violations defined person role limited transporting storing drugs money directs review amend guidelines policy statements applicable persons convicted offense csa csiea ensure consistency act consider specified factors including mandate formulate guidelines minimize likelihood federal prison population exceed federal prison capacity need reduce prevent racial disparities sentencing requires attorney general report reduced expenditures federal corrections cost savings resulting act help reduce bureau_of_prisons increase investment law enforcement crime prevention reduce recidivism report list criminal statutory offenses potential criminal penalty number prosecutions brought department_of_justice year previous years requirement offense establish publicly accessible index criminal statutory offense


Summary:
Comprehensive Addiction and Recovery Act of 2015

 Directs the Department of Health and Human Services (HHS) to convene a Pain Management Best Practices Inter-Agency Task Force to develop: (1) best practices for pain management and prescribing pain medication, and (2) a strategy for disseminating such best practices.

Amends the Omnibus Crime Control and Safe Streets Act of 1968 to authorize the Attorney General to make grants to:

 states (with priority to states that provide civil liability protection for first responders, health professionals, and family members administering naloxone to counteract opioid overdoses), local governments, and nonprofit organizations to expand educational efforts to prevent abuse of opioids, heroin, and other substances of abuse, understand addiction as a chronic disease, and promote treatment and recovery; organizations that have received a grant under the Drug-Free Communities Act of 1997 to implement comprehensive community-wide strategies that address local drug crises; states (with priority to states that provide civil liability protection for administering naloxone), local governments, Indian tribes, and nonprofit organizations for treatment alternative to incarceration programs for individuals who have come into contact with the juvenile or criminal justice system or have been arrested or charged with an offense, who have a substance use disorder, mental illness, or both, and who have been approved for participation in such a program; state, local, or tribal law enforcement agencies to create a demonstration law enforcement program to prevent opioid and heroin overdose death; state, local, or tribal law enforcement agencies, manufacturers, distributors, or reverse distributor of prescription medications, retail pharmacies, registered narcotic treatment programs, hospitals or clinics with an on-site pharmacy, eligible long-term care facilities, or any other entity authorized by the Drug Enforcement Administration to dispose of prescription medications to expand or make available disposal sites for unwanted prescription medications; states (with priority to states that provide civil liability protection for administering naloxone), local governments, and Indian tribes to implement medication assisted treatment programs through their criminal justice agencies; states, local governments, nonprofit organizations, and Indian tribes for educational programs for incarcerated offenders; state substance abuse and criminal justice agencies, jointly, to address the use of opioids and heroin among pregnant and parenting female offenders in a state to promote public safety, public health, family permanence, and well-being; establish or expand veterans treatment court programs, peer to peer services or programs for qualified veterans, practices that identify and provide treatment, rehabilitation, legal, and transitional services to incarcerated veterans, and training programs to teach criminal justice, mental health, and substance abuse personnel how to identify and appropriately respond to incidents involving veterans; and states to prepare a comprehensive plan for and implement an integrated opioid abuse response initiative. Amends the Public Health Service Act to authorize the Center for Substance Abuse Treatment to award grants to enable state substance abuse agencies, local governments, nonprofit organizations, and Indian tribes or tribal organizations that have a high rate of, or have had a rapid increase in, the use of heroin or other opioids to expand activities, including medication assisted treatment, for the treatment of addiction in the geographical areas affected.

Authorizes the Recovery Branch of the Office of National Drug Control Policy to award grants to: (1) enable high schools and colleges with substance abuse recovery programs and nonprofit organizations to provide substance abuse recovery support services to high school and college students, to help build communities of support for young people in recovery, and to encourage initiatives designed to help young people achieve and sustain recovery; and (2) enable recovery community organizations to develop, expand, and enhance recovery services.

Amends the Higher Education Act of 1965 to prohibit the Department of Education from including any question about the conviction of an applicant for the possession or sale of illegal drugs on the Free Application for Federal Student Aid form.

Directs HHS to establish a bipartisan Task Force on Recovery and Collateral Consequences to: (1) identify collateral consequences for individuals with drug convictions who are in recovery for a substance use disorder, and (2) determine whether such consequences unnecessarily delay such individuals from resuming their personal and professional activities.

Amends the Omnibus Crime Control and Safe Streets Act to direct the Attorney General to report annually on how grants awarded under such Act are used for family-based substance abuse treatment programs that serve as alternatives to incarceration for custodial parents to receive treatment and services as a family.

Expresses the sense of Congress that the amounts expended to carry out this Act should be offset by a corresponding reduction in federal non-defense discretionary spending.

Directs the Comptroller General to report on the impact that the Medicaid Institutions for Mental Disease exclusion (defined as the prohibition on federal matching payments under Medicaid for patients who have attained age 22, but have not attained age 65, in an institution for mental diseases) has on access to treatment for individuals with a substance use disorder.

comprehensive addiction recovery act directs_the_department_of_health_and_human_services hhs convene pain management best practices inter agency task force develop best practices pain management prescribing pain medication strategy disseminating best practices amends omnibus_crime_control_and_safe_streets_act authorize attorney general grants states priority states provide civil liability protection responders health professionals family members administering naloxone opioid local governments nonprofit organizations expand educational efforts prevent abuse opioids heroin substances abuse understand addiction chronic disease promote treatment recovery organizations received grant implement comprehensive community wide strategies address local drug crises states priority states provide civil liability protection administering naloxone local governments indian tribes nonprofit organizations treatment alternative incarceration programs individuals come contact juvenile criminal justice system arrested charged offense substance use disorder mental illness approved participation program state local tribal law enforcement agencies create demonstration law enforcement program prevent opioid heroin overdose death state local tribal law enforcement agencies manufacturers distributors reverse distributor prescription medications retail pharmacies registered narcotic treatment programs hospitals clinics site pharmacy eligible long term care facilities entity authorized drug_enforcement_administration dispose prescription medications expand available disposal sites unwanted prescription medications states priority states provide civil liability protection administering naloxone local governments indian tribes implement medication assisted treatment programs criminal justice agencies states local governments nonprofit organizations indian tribes educational programs incarcerated offenders state substance abuse criminal justice agencies jointly address use opioids heroin pregnant parenting female offenders state promote public safety public health family establish expand veterans treatment court programs peer peer services programs qualified veterans practices identify provide treatment rehabilitation legal transitional services incarcerated veterans training programs teach criminal justice mental health substance abuse personnel identify appropriately respond incidents involving veterans states prepare comprehensive plan implement integrated opioid abuse response initiative amends public_health_service_act authorize center_for_substance_abuse_treatment award grants enable state substance abuse agencies local governments nonprofit organizations indian tribes tribal organizations high rate rapid increase use heroin opioids expand activities including medication assisted treatment treatment addiction geographical areas affected authorizes recovery branch office_of_national_drug_control_policy award grants enable high schools colleges substance abuse recovery programs nonprofit organizations provide substance abuse recovery support services high school college students help build communities support young people recovery encourage initiatives designed help young people achieve sustain recovery enable recovery community organizations develop expand enhance recovery services amends higher education act prohibit department_of_education including question conviction applicant possession sale illegal drugs free_application_for_federal_student_aid form directs hhs establish bipartisan task force recovery collateral consequences identify collateral consequences individuals drug convictions recovery substance use disorder determine consequences unnecessarily delay individuals resuming personal professional activities amends omnibus_crime_control_and_safe_streets_act direct attorney general report annually grants awarded act family based substance abuse treatment programs serve alternatives incarceration custodial parents receive treatment services family expresses sense congress amounts expended carry act offset corresponding reduction federal non defense discretionary spending directs comptroller general report impact medicaid institutions mental disease exclusion defined prohibition federal matching payments medicaid patients attained age attained age institution mental diseases access treatment individuals substance use disorder


Summary:
Regulate Marijuana Like Alcohol Act

 Directs the Attorney General to issue a final order that removes marijuana in any form from all schedules of controlled substances under the Controlled Substances Act.

Amends such Act to: (1) provide that schedules I, II, III, IV, and V shall consist of the drugs and other substances that are set forth in the respective schedules in part 1308 of title 21 of the Code of Federal Regulations; (2) exempt marijuana from such Act except as provided in this Act; (3) revise the definition of "felony drug offense" to exclude conduct relating to marijuana; and (4) eliminate marijuana from provisions setting forth penalties applicable to prohibited conduct under such Act.

Prohibits shipping or transporting marijuana from any place outside a jurisdiction of the United States into such a jurisdiction in which its possession, use, or sale is prohibited.

Eliminates marijuana as: (1) a controlled substance for purposes of the Controlled Substances Import and Export Act or the National Forest System Drug Control Act of 1986, (2) a dangerous drug for purposes of federal criminal code provisions authorizing interception of communications, and (3) a targeted drug for purposes of provisions of the national youth anti-drug media campaign under the Office of National Drug Control Policy Reauthorization Act of 1998.

Amends the Federal Alcohol Administration Act to set forth procedures for the issuance and revocation by the Secretary of the Treasury of permits for importing, shipping or selling in interstate or foreign commerce, purchasing for resale, producing, packaging, or warehousing marijuana. Prohibits any person from engaging in such conduct without a permit, subject to a $1,000 fine and/or a $500 payment. Sets forth criteria for ineligible applicants and disqualifying offenses.

Subjects marijuana to the provisions that apply to: (1) intoxicating liquors under the Original Packages Act, the Webb-Kenyon Act, and the Victims of Trafficking and Violence Protection Act of 2000; and (2) distilled spirits under the Federal Alcohol Administration Act.

Grants the Food and Drug Administration the same authorities with respect to marijuana as it has for alcohol. Transfers functions of the Administrator of the Drug Enforcement Administration relating to marijuana enforcement to the Director of the Bureau of Alcohol, Tobacco, Firearms, and Explosives (ATF). Renames: (1) ATF as the Bureau of Alcohol, Tobacco, Marijuana, Firearms and Explosives; and (2) the Alcohol and Tobacco Tax and Trade Bureau as the Alcohol, Tobacco, and Marijuana Tax and Trade Bureau.

Directs the Comptroller General to review federal laws, regulations, and policies to determine if changes are desirable in light of this Act.

regulate marijuana like directs attorney general issue final order removes marijuana form schedules controlled substances controlled substances act amends act provide schedules iii shall consist drugs substances set forth respective schedules title code federal regulations exempt marijuana act provided act revise definition felony drug offense exclude conduct relating marijuana eliminate marijuana provisions setting forth penalties applicable prohibited conduct act prohibits shipping transporting marijuana place outside jurisdiction united_states jurisdiction possession use sale prohibited eliminates marijuana controlled substance purposes controlled_substances_import_and_export_act dangerous drug purposes federal criminal code provisions authorizing interception communications targeted drug purposes provisions national youth anti drug media campaign office_of_national_drug_control_policy_reauthorization_act amends set forth procedures issuance revocation secretary treasury permits importing shipping selling interstate foreign commerce purchasing resale producing packaging warehousing marijuana prohibits person engaging conduct permit subject fine payment sets forth criteria ineligible applicants disqualifying offenses subjects marijuana provisions apply intoxicating original packages act act victims_of_trafficking_and_violence_protection_act distilled spirits authorities respect marijuana alcohol transfers functions administrator drug_enforcement_administration relating marijuana enforcement director explosives atf renames atf directs comptroller general review federal laws regulations policies determine changes desirable light act


Summary:
Marijuana Tax Revenue Act of 2015

This bill amends the Internal Revenue Code to impose an excise tax on: (1) the sale of marijuana by producers or importers, and (2) each person who is engaged in a marijuana enterprise. Defines "marijuana enterprise" to mean a producer, importer, manufacturer, distributor, retailer or any person who transports, stores, displays, or otherwise participates in any business activity that handles marijuana or marijuana products.

Any person who engages in a marijuana enterprise must obtain a permit to engage in such an enterprise.

The bill imposes civil penalties for failure to comply with the requirements of this Act and criminal penalties for engaging in a marijuana enterprise without a permit, failing to keep or make required records or for making false records, or refusing to pay or evading a tax imposed by this Act and for other offenses related to the sale of marijuana.

bill amends internal_revenue_code impose excise tax sale marijuana producers importers person engaged marijuana enterprise defines marijuana enterprise mean producer importer manufacturer distributor retailer person transports stores displays participates business activity handles marijuana marijuana products person engages marijuana enterprise obtain permit engage enterprise bill imposes civil penalties failure comply requirements act criminal penalties engaging marijuana enterprise permit failing required records making false records refusing pay evading tax imposed act offenses related sale marijuana


Summary:
Synthetic Abuse and Labeling of Toxic Substances Act of 2015 or the SALTS Act

Amends the Controlled Substances Act to authorize the following factors to be considered in determining whether a controlled substance analogue was intended for human consumption:

 the marketing, advertising, and labeling of the substance; the known efficacy or usefulness of the substance for the marketed, advertised, or labeled purpose; the difference between the price at which the substance is sold and the price at which the substance it is purported to be or advertised as is normally sold; the diversion of the substance from legitimate channels and the clandestine importation, manufacture, or distribution of the substance; whether the defendant knew or should have known that the substance was intended to be consumed by injection, inhalation, ingestion, or any other immediate means; and whether the substance is manufactured, formulated, sold, distributed, or marketed with the intent to avoid the provisions of existing drug laws. Declares that evidence that a substance was not marketed, advertised, or labeled for human consumption shall not by itself be sufficient to establish that the substance was not intended for human consumption.

labeling toxic substances act salts act amends controlled substances act authorize following factors considered determining controlled substance analogue intended human consumption marketing advertising labeling substance known efficacy usefulness substance marketed advertised labeled purpose difference price substance sold price substance purported advertised normally sold diversion substance legitimate channels clandestine importation manufacture distribution substance defendant knew known substance intended consumed injection inhalation ingestion immediate means substance manufactured formulated sold distributed marketed intent avoid provisions existing drug laws declares evidence substance marketed advertised labeled human consumption shall sufficient establish substance intended human consumption


Summary:
Fair Sentencing Clarification Act of 2015

 Directs: (1) a court, in cases in which a sentence has not yet been imposed with respect to the application of the penalty amendments of the Fair Sentencing Act of 2010 to cocaine base offenses committed prior to the enactment of such Act, to impose such sentence as if such amendments were in effect on the date the offense was committed; and (2) the Court of Appeals to remand for resentencing consistent with such amendments such cases in which a sentence has already been imposed, if subject to a pending appeal on or after August 3, 2010.

Authorizes the sentencing court, in the case of a defendant who has been convicted of such an offense committed before August 3, 2010, for which a term of imprisonment has been imposed, to reduce the term of imprisonment for that crime consistent with the amendments made by that Act on motion of the defendant or the Director of the Bureau of Prisons, or on its own motion.

fair sentencing clarification act directs court cases sentence imposed respect application penalty amendments fair sentencing act cocaine base offenses committed prior enactment act impose sentence amendments effect date offense committed court_of_appeals remand consistent amendments cases sentence imposed subject pending appeal august authorizes sentencing court case defendant convicted offense committed august term imprisonment imposed reduce term imprisonment crime consistent amendments act motion defendant director bureau_of_prisons motion


Summary:
Fairness in Cocaine Sentencing Act of 2015

Amends the Controlled Substances Act and the Controlled Substances Import and Export Act to eliminate increased and mandatory minimum penalties for drug offenses involving mixtures or substances which contain cocaine base (i.e., crack cocaine).

fairness amends controlled substances act controlled_substances_import_and_export_act eliminate increased mandatory minimum penalties drug offenses involving mixtures substances contain cocaine base crack cocaine


Summary:
Compassionate Access, Research Expansion, and Respect States Act of 2015 or the CARERS Act of 2015

Amends the Controlled Substances Act (CSA) to provide that control and enforcement provisions of such Act relating to marihuana shall not apply to any person acting in compliance with state law relating to the production, possession, distribution, dispensation, administration, laboratory testing, or delivery of medical marihuana.

Transfers marihuana from schedule I to schedule II of the CSA.

Excludes "cannabidiol" from the definition of "marihuana" and defines it separately as the substance cannabidiol, as derived from marihuana or the synthetic formulation, that contains not greater than 0.3% delta-9-tetrahydrocannabinol on a dry weight basis. Deems marihuana that is grown or possessed for purposes of making cannabidiol, in accordance with state law, to meet such concentration limitation unless the Attorney General determines that the state law is not reasonably calculated to comply with such definition.

Prohibits a federal banking regulator from: (1) terminating or limiting the deposit insurance of a depository institution solely because it provides or has provided financial services to a marihuana-related legitimate business; or (2) prohibiting, penalizing, or otherwise discouraging a depository institution from providing financial services to a marihuana-related legitimate business.

Prohibits a federal banking regulator from recommending, motivating, providing incentives, or encouraging a depository institution not to offer financial services to an individual, or to downgrade or cancel financial services offered to an individual, solely because: (1) the individual is a manufacturer of marihuana, (2) the individual is or later becomes an owner or operator of a marihuana-related legitimate business, or (3) the depository institution was not aware that the individual is the owner or operator of a marihuana-related legitimate business.

Prohibits a federal banking regulator from taking any adverse or corrective supervisory action on a loan to an owner or operator of: (1) a marihuana-related legitimate business soley because the owner or operator is such a business, or (2) real estate or equipment that is leased to a marihuana-related legitimate business solely because it is leased to such a business.

Provides depository institutions that provide financial services to a marihuana-related legitimate business protection under federal law from federal criminal prosecution or investigation, criminal penalties, and forfeiture of legal interest in collateral solely for providing financial services to such a business.

Directs: (1) the Department of Health and Human Services to terminate the Public Health Service interdisciplinary review process described in the guidance entitled "Guidance on Procedures for the Provision of marihuana for Medical Research" (issued on May 21, 1999), and (2) the Drug Enforcement Administration to issue at least three licenses under CSA registration requirements to manufacture marihuana and marihuana-derivatives for research approved by the Food and Drug Administration.

Directs the Department of Veterans Affairs (VA) to authorize VA health care providers to provide veterans with recommendations and opinions regarding participation in state marihuana programs.

compassionate access research expansion respect states act act amends controlled substances act csa provide control enforcement provisions act relating marihuana shall apply person acting compliance state law relating production possession distribution dispensation administration laboratory testing delivery medical marihuana transfers marihuana schedule schedule csa excludes cannabidiol definition marihuana defines separately substance cannabidiol derived marihuana synthetic formulation contains greater delta-9 tetrahydrocannabinol dry weight basis deems marihuana grown possessed purposes making cannabidiol accordance state law meet concentration limitation attorney general determines state law reasonably calculated comply definition prohibits federal banking regulator terminating limiting deposit insurance depository institution solely provides provided financial services marihuana related legitimate business prohibiting penalizing discouraging depository institution providing financial services marihuana related legitimate business prohibits federal banking regulator recommending motivating providing incentives encouraging depository institution offer financial services individual downgrade cancel financial services offered individual solely individual manufacturer marihuana individual later owner operator marihuana related legitimate business depository institution aware individual owner operator marihuana related legitimate business prohibits federal banking regulator taking adverse corrective supervisory action loan owner operator marihuana related legitimate business owner operator business real estate equipment leased marihuana related legitimate business solely leased business provides depository institutions provide financial services marihuana related legitimate business protection federal law federal criminal prosecution investigation criminal penalties forfeiture legal interest collateral solely providing financial services business directs department_of_health_and_human_services terminate public_health_service interdisciplinary review process described guidance entitled guidance procedures provision marihuana medical research issued drug_enforcement_administration issue licenses csa registration requirements manufacture marihuana marihuana derivatives research approved food_and_drug_administration directs department_of_veterans_affairs authorize health care providers provide veterans recommendations opinions participation state marihuana programs


Summary:
Charlotte's Web Medical Access Act of 2015

 Amends the Controlled Substances Act (CSA) to exclude cannabidiol and cannabidiol-rich plants: (1) from the definition of "marihuana," and (2) from treatment as a controlled substance under such Act. Defines: (1) "cannabidiol-rich plant" to mean the plant Cannabis sativa L. and any part of such plant with a delta-9 tetrahydrocannabinol concentration of not more than 0.3% on a dry weight basis; and (2) "cannabidiol" to mean the substance cannabidiol, as derived from a cannabidiol-rich plant.

Exempts cannabidiol or cannabidiol-rich plants from the Federal Food, Drug, and Cosmetic Act.

Declares that nothing in this Act shall restrict any activities related to the use, production, or distribution of marihuana in a state in which such activities are legal under state law.

Terminates this Act three years after its enactment.

web medical access act amends controlled substances act csa exclude cannabidiol cannabidiol rich plants definition marihuana treatment controlled substance act defines cannabidiol rich plant mean plant cannabis sativa plant delta-9 tetrahydrocannabinol concentration dry weight basis cannabidiol mean substance cannabidiol derived cannabidiol rich plant exempts cannabidiol cannabidiol rich plants cosmetic act declares act shall restrict activities related use production distribution marihuana state activities legal state law terminates act years enactment


Summary:
Compassionate Access Act

This bill directs the Department of Health and Human Services to submit to the Drug Enforcement Administration (DEA) a recommendation to transfer marijuana from schedule I to another controlled substances schedule. The DEA must consider the recommendation and issue a final rule to reclassify marijuana.

It permits, for reclassification purposes, consideration of scientifically sound research conducted in a state that allows medical marijuana and in accordance with state law, even if such research uses non-federally approved marijuana.

The legislation amends the Controlled Substances Act (CSA) to:

 exclude "cannabidiol" (CBD) from the definition of "marijuana" and remove it from coverage under the CSA; limit the concentration of delta-9-tetrahydrocannabinol (THC) in CBD to 0.3% on a dry weight basis; and deem marijuana grown or processed to make CBD, in accordance with state law, to comply with the THC concentration limit unless the DEA determines state law to be unreasonable. No provision of the CSA or Federal Food, Drug, and Cosmetic Act prohibits or restricts a physician from prescribing; a patient, caregiver, or guardian from obtaining, possessing, or transporting; an entity from producing, processing, manufacturing, or distributing; a pharmacy from dispensing; or a laboratory from testing medical marijuana or CBD in compliance with a state's medical marijuana law.

The bill requires the Attorney General to delegate responsibility for registering marijuana researchers to an executive branch agency that supports research on substances' medical value. Such agency must ensure adequate marijuana supply for medical research.

compassionate access act bill directs department_of_health_and_human_services submit drug_enforcement_administration dea recommendation transfer marijuana schedule controlled substances schedule dea consider recommendation issue final rule reclassify marijuana permits reclassification purposes consideration scientifically sound research conducted state allows medical marijuana accordance state law research uses non federally approved marijuana legislation amends controlled substances act csa exclude cannabidiol definition marijuana remove coverage csa limit concentration delta-9 tetrahydrocannabinol dry weight basis deem marijuana grown processed accordance state law comply concentration limit dea determines state law unreasonable provision csa cosmetic act prohibits restricts physician prescribing patient caregiver guardian obtaining possessing transporting entity producing processing manufacturing distributing pharmacy dispensing laboratory testing medical marijuana compliance state medical marijuana law bill requires attorney general delegate responsibility registering marijuana researchers executive branch agency supports research substances medical value agency ensure adequate marijuana supply medical research


Summary:
Western Hemisphere Drug Policy Commission Act

 Establishes the Western Hemisphere Drug Policy Commission, which shall: (1) conduct a comprehensive review of U.S. foreign policy in the Western Hemisphere to reduce the illicit drug supply and drug abuse and reduce the damage associated with illicit drug markets and trafficking, and (2) identify policy and program options to improve existing international and domestic counternarcotics policy.

act establishes shall conduct comprehensive review foreign policy western_hemisphere reduce illicit drug supply drug abuse reduce damage associated illicit drug markets trafficking identify policy program options improve existing international domestic counternarcotics policy


Summary:
Small Business Tax Equity Act of 2015

Amends the Internal Revenue Code to exempt a trade or business that conducts marijuana sales in compliance with state law from the prohibition against allowing business-related tax credits or deductions for expenditures in connection with trafficking in controlled substances.

amends internal revenue code exempt trade business conducts marijuana sales compliance state law prohibition allowing business related tax credits deductions expenditures connection trafficking controlled substances


Summary:
Respect State Marijuana Laws Act of 2015

 Amends the Controlled Substances Act to provide that provisions of such Act related to marihuana shall not apply to any person acting in compliance with state laws relating to the production, possession, distribution, dispensation, administration, or delivery of marijuana.

respect state amends controlled substances act provide provisions act related marihuana shall apply person acting compliance state laws relating production possession distribution dispensation administration delivery marijuana


Summary:
Ensuring Quality in the Unemployment Insurance Program (EQUIP) Act

 Amends title III (Grants to States for Unemployment Compensation Administration) of the Social Security Act (SSAct) to require state unemployment compensation (UC) laws to require, as a condition of UC eligibility for a benefit year, an applicant, before receiving any UC, to: (1) complete a substance abuse risk assessment; and (2) test negative for controlled substances within one week after the results of such assessment if the state determines that the applicant is a high-risk. Prescribes retesting requirements and UC payment suspensions for applicants who test positive.

Amends SSAct title XVIII (Medicare) and the Patient Protection and Affordable Care Act to provide funding for such substance abuse testing out of current funds appropriated for the Independent Payment Advisory Board and, after application of those funds, for the Consumer Operated and Oriented Plan program.

ensuring quality equip act amends title iii grants states unemployment compensation administration social security act ssact require state unemployment compensation laws require condition eligibility benefit year applicant receiving complete substance abuse risk assessment test negative controlled substances week results assessment state determines applicant high risk prescribes requirements payment suspensions applicants test positive amends ssact title xviii medicare patient_protection affordable care act provide funding substance abuse testing current funds appropriated independent_payment_advisory_board application funds oriented plan program


Summary:
Reclassification to Ensure Smarter and Equal Treatment Act of 2015 or the RESET Act

 Amends the Controlled Substances Act (CSA) to reduce penalties (to not greater than a one-year term of imprisonment and/or a $1,000 fine) for simple possession of a controlled substance by a person who has one or more prior convictions for a controlled substance offense.

Repeals a provision providing for up to three years' imprisonment for the possession of flunitrazepam. Revises penalties for possession of drugs classified as date rape drugs after a prior drug-related conviction.

Reduces the maximum term of imprisonment (to one year) for the sale, use of the mails to transport, or importation or exportation of drug paraphernalia.

Eliminates provisions of the CSA and the Controlled Substances Import and Export Act that apply the same penalties applicable to offenses involving a specified amount of a substance containing cocaine to offenses involving a lesser amount of a substance containing cocaine base.

Amends the CSA to provide that in determining the weight of a controlled substance or mixture of controlled substances that is in a compound with a food product for purposes of provisions concerning controlled substance offenses, the weight of the food product shall not be included.

Makes this Act applicable to any offense committed before its enactment, if a sentence for the offense has not been imposed as of such enactment date. Provides for the reduction of the term of imprisonment of a defendant who was convicted and sentenced before such date for an offense for which the penalty is amended by this Act.

Directs the Sentencing Commission to review and, if appropriate, amend the federal sentencing guidelines and policy statements applicable to any person convicted of an offense affected by this Act.

Establishes within the Department of Justice the Safe Neighborhoods and Schools Fund, which (subject to specified limitations) shall be disbursed as follows by August 15 of each fiscal year beginning in 2016:

 15% to the Department of Education to administer a grant program to public agencies aimed at improving outcomes for public school pupils in kindergarten and grades 1 to 12 by reducing truancy and supporting students who are at risk of dropping out or are victims of crime; 10% to the Federal Crime Victim Assistance Fund to make grants to trauma recovery centers to provide services to victims of crime; 25% to Federal Reentry/Drug Court programs to administer a grant program to public agencies aimed at supporting mental health treatment, substance abuse treatment, and diversion programs for people in the criminal justice system; and 50% to the General Treasury in order to pay down the national debt.

reclassification ensure smarter equal treatment act reset act amends controlled substances act csa reduce penalties greater year term imprisonment fine simple possession controlled substance person prior convictions controlled substance offense repeals provision providing years imprisonment possession flunitrazepam revises penalties possession drugs classified date rape drugs prior drug related conviction reduces maximum term imprisonment year sale use mails transport importation exportation drug eliminates provisions csa controlled_substances_import_and_export_act apply penalties applicable offenses involving specified substance containing cocaine offenses involving lesser substance containing cocaine base amends csa provide determining weight controlled substance mixture controlled substances compound food product purposes provisions concerning controlled substance offenses weight food product shall included makes act applicable offense committed enactment sentence offense imposed enactment date provides reduction term imprisonment defendant convicted sentenced date offense penalty amended act review appropriate amend federal sentencing guidelines policy statements applicable person convicted offense affected act establishes subject specified limitations shall disbursed follows august fiscal year beginning department_of_education administer grant program public agencies aimed improving outcomes public school kindergarten grades reducing truancy supporting students risk victims crime grants trauma recovery centers provide services victims crime programs administer grant program public agencies aimed supporting mental health treatment substance abuse treatment diversion programs people criminal justice system order pay national debt


Summary:
Amends the Controlled Substances Import and Export Act to allow exported controlled substances to be re-exported within the European Economic Area.

Prohibits the Attorney General from promulgating or enforcing any regulation, subregulatory guidance, or enforcement policy that impedes such re-exportation among European Economic Area countries.

amends controlled_substances_import_and_export_act allow exported controlled substances exported prohibits attorney general promulgating enforcing regulation guidance enforcement policy impedes exportation countries


Summary:
Legitimate Use of Medical Marijuana Act or the LUMMA

Transfers marijuana from schedule I to schedule II of the Controlled Substances Act (CSA).

Provides that in a state in which marijuana may be prescribed for medical use under state law, no provision of the CSA or of the Federal Food, Drug, and Cosmetic Act shall prohibit or otherwise restrict: (1) the prescription of marijuana for medical use; (2) an authorized patient from obtaining, possessing, transporting, or using marijuana for that individual's medical use; (3) an individual from obtaining, possessing, transporting, or manufacturing marijuana pursuant to an authorization under state law; (4) a pharmacy or other entity authorized under state law to distribute medical marijuana to an authorized patient for medical use from obtaining, possessing, or distributing marijuana for that purpose; or (5) an entity authorized by such state from producing, processing, or distributing marijuana for  prescribed medical use.

legitimate use medical transfers marijuana schedule schedule controlled substances act csa provides state marijuana prescribed medical use state law provision csa cosmetic act shall prohibit restrict prescription marijuana medical use authorized patient obtaining possessing transporting marijuana individual medical use individual obtaining possessing transporting manufacturing marijuana pursuant authorization state law pharmacy entity authorized state law distribute medical marijuana authorized patient medical use obtaining possessing distributing marijuana purpose entity authorized state producing processing distributing marijuana prescribed medical use


Summary:
Opioid Addiction Treatment Modernization Act

 This bill amends the Controlled Substances Act to require a practitioner who administers or dispenses narcotic drugs for maintenance or detoxification treatment in an opioid treatment program to complete training every two years.

 The legislation revises the waiver requirements for a physician who wants to administer, dispense, or prescribe narcotic drugs for maintenance or detoxification treatment in an office-based opioid treatment program. Currently, such physician must notify the Department of Health and Human Services (HHS) and certify that he or she is a qualifying physician, has the capacity to refer patients for appropriate counseling and ancillary services, and will comply with a patient limit. This bill requires a physician to also certify that he or she maintains a diversion control plan and has the capacity to provide directly or by referral all drugs approved by the Food and Drug Administration for the treatment of opioid addiction.

 The bill modifies the definition of a "qualifying physician." Currently, a qualifying physician must be licensed in a state and have expertise (such as relevant certification, training, or experience). This legislation requires a qualifying physician to also complete training every two years and obtain written consent from each patient regarding available treatment options.

 It permits HHS or the Department of Justice to inspect registered practitioners who dispense narcotics to ensure compliance with the requirements of this Act.

 All practitioners who are permitted to dispense narcotic drugs to individuals for maintenance treatment or detoxification treatment must submit to HHS a certification of compliance with the requirements of this Act.

 The Government Accountability Office must review opioid addition treatment services in the United States and report findings to Congress every five years.

bill amends controlled substances act require practitioner administers dispenses narcotic drugs maintenance detoxification treatment opioid treatment program complete training years legislation revises waiver requirements physician wants administer dispense prescribe narcotic drugs maintenance detoxification treatment office based opioid treatment program currently physician notify department_of_health_and_human_services hhs certify qualifying physician capacity refer patients appropriate counseling ancillary services comply patient limit bill requires physician certify maintains diversion control plan capacity provide directly referral drugs approved food_and_drug_administration treatment opioid addiction bill modifies definition qualifying physician currently qualifying physician licensed state expertise relevant certification training experience legislation requires qualifying physician complete training years obtain written consent patient available treatment options permits hhs department_of_justice inspect registered practitioners dispense narcotics ensure compliance requirements act practitioners permitted dispense narcotic drugs individuals maintenance treatment detoxification treatment submit hhs certification compliance requirements act government_accountability_office review opioid addition treatment services united_states report findings congress years


Summary:
Medical Controlled Substances Transportation Act of 2015

This bill amends the Controlled Substances Act to allow a physician to transport controlled substances to another practice setting or disaster area if the physician is registered to dispense, or conduct research with, controlled substances listed on schedules II, III, IV, or V, and the physician enters into a specific agreement with the Drug Enforcement Administration (DEA).

The agreement must require a physician to provide advance notification to the DEA, limit the duration of transport to 72 hours, and maintain records of the controlled substances dispensed. A “disaster area” is the area covered by a President's major disaster declaration.

transportation act bill amends controlled substances act allow physician transport controlled substances practice setting disaster area physician registered dispense conduct research controlled substances listed schedules iii physician enters specific agreement drug_enforcement_administration dea agreement require physician provide advance notification dea limit duration transport hours maintain records controlled substances dispensed disaster area area covered president major disaster declaration


Summary:
Clean Slate for Marijuana Offenses Act of 2015

Amends the federal criminal code to allow an individual convicted of a qualifying marijuana-related offense, upon filing a petition for expungement and fulfilling all requirements of the sentence for such conviction, to obtain an order granting expungement of such conviction.

Defines a "qualifying marijuana-related offense" as an offense against the United States in which the conduct constituting the offense: (1) was legal under the state law at the time of the offense, or (2) was the possession of not more than one ounce of marijuana.

 Gives the government 60 days to contest such a petition, in which case the court shall allow the government and the petitioner an opportunity to present evidence and argument relating to the petition. Directs the court to approve or deny the petition based on its determination that the petition either is supported by, or is not supported by, a preponderance of the evidence.

Declares that: (1) an order granting expungement restores the individual concerned to the status that individual occupied before the arrest or the institution of criminal proceedings for the offense for which expungement is granted; (2) the individual is not required to divulge information pertaining to an expunged conviction and such conviction shall not disqualify that individual from pursuing or engaging in any lawful activity, occupation, or profession; (3) such individual is not guilty of making a false statement by reason of that individual's failure to recite or acknowledge arrest or conviction of such offense; and (4) records pertaining to an expunged conviction shall be destroyed.

Directs the Department of Justice (DOJ) to maintain a nonpublic record of such expungement orders and the names of and alphanumeric identifiers selected by DOJ for persons who obtain expungement, which record shall be made available only to the individual to whom the expungement pertains. Establishes penalties for the unauthorized disclosure of information relating to an expunged conviction.

amends federal criminal code allow individual convicted qualifying marijuana related offense filing petition expungement fulfilling requirements sentence conviction obtain order granting expungement conviction defines qualifying marijuana related offense offense united_states conduct constituting offense legal state law time offense possession marijuana gives government days contest petition case court shall allow government petitioner opportunity present evidence argument relating petition directs court approve deny petition based determination petition supported supported preponderance evidence declares order granting expungement restores individual concerned status individual occupied arrest institution criminal proceedings offense expungement granted individual required information pertaining expunged conviction conviction shall disqualify individual pursuing engaging lawful activity occupation profession individual guilty making false statement reason individual failure acknowledge arrest conviction offense records pertaining expunged conviction shall destroyed directs department_of_justice doj maintain nonpublic record expungement orders names identifiers selected doj persons obtain expungement record shall available individual expungement pertains establishes penalties unauthorized disclosure information relating expunged conviction